Stanford Brain Metastases Consortium

A multidisciplinary, collaborative, and driven approach to improving outcomes for patients with brain metastases.

The Stanford Brain Metastases Consortium is a unique partnership between scientists, physicians and surgeons from across the Stanford community, that brings together experts in research and clinical care of brain metastases. Through more focused and collaborative efforts, our goal is to increase the number of available clinical trials and collaborative publications, and to enhance our patients' experience through a team-based approach to care. Meet our Team >

Research

The Brain Metastases Consortium facilitates collaborative research between the many exceptional researchers and clinicians at Stanford University. These projects involve specialists from different departments, whose combined efforts can exponentially advance our understanding of, and capacity to treat, metastatic brain tumors. Interests include cancer biology, radiation oncology, neuroscience, immunology, medical oncology, neurosurgery, physics, bio-engineering, neuro oncology, and population science, among others. 

Featured Publications:

Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions

Authors: Jessica A Wilcox, Ugonma N Chukwueke, Myung-Ju Ahn, Ayal A Aizer, Tejus A Bale, Dieta Brandsma, Priscilla K Brastianos, Susan Chang, Mariza Daras, Peter Forsyth, Livia Garzia, Michael Glantz, Isabella C Glitza Oliva, Priya Kumthekar, Emilie Le Rhun, Seema Nagpal, Barbara O’Brien, Elena Pentsova, Eudocia Quant Lee, Jan Remsik, Roberta Rudà, Inna Smalley, Michael D Taylor, Michael Weller, Jeffrey Wefel, Jonathan T Yang, Robert J Young, Patrick Y Wen, Adrienne A Boire.

Published: Neuro-Oncology, June 2024


Durable responses to trastuzumab deruxtecan in patients with leptomeningeal metastases from breast cancer with variable HER2 expression

Authors: David Rogawski, Toni Cao, Qian Ma, Meaghan Roy-O’Reilly, Lilian Yao, Nova Xu & Seema Nagpal.

Published: J Neurooncol, July 2024


New Award: Stanford BMC Awarded Stanford Cancer Institute Funding

SCI Innovation Awards celebrate the dedication of some of Stanford’s most innovative thinkers. The Stanford BMC was recently awarded the SCI Nodal Grant Award for its project: “Expanding the Reach of the Stanford Brain Metastases Consortium: Deep Profiling of Brain Metastases through Multiplexed Analysis and Multi-PI Collaborations.”

Video: New Technology Can Make Brain Surgery Safer

Meetings

Research Speed-Dating Symposium

On March 18, 2022, the BMC held a speed dating event which brought our experts together to collaborate on research goals. Stanford students, trainees, staff, and faculty attended. We announced the details of a new seed grant program of $50,000 to fund new brain mets collaborations, made possible by our recently funded U54 program grant.

Featured Clinical Trial

Our Patients

Lung Cancer Patient Finds Health Again at Stanford

Eight years after being diagnosed with stage-4 lung cancer, whose treatment led to other health complications - including six brain tumors - Ginger Powell is now cancer-free.